日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Virtual Ligand-Assisted Screening for the Generation of Ketyl Radicals from Alkyl Ketones via Photoexcited Palladium Catalysis

利用虚拟配体辅助筛选方法,通过光激发钯催化由烷基酮生成酮基自由基

Tanaka, Kosaku 3rd; Yamada, Ren; Debbarma, Suvankar; Kanna, Wataru; Hayashi, Hiroki; Matsuoka, Wataru; Maeda, Satoshi; Mita, Tsuyoshi

Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCC.

血清 FGF21 作为预测 HCC 对阿特珠单抗和贝伐珠单抗反应的指标

Kohya Risako, Suda Goki, Ohara Masatsugu, Hosoda Shunichi, Sho Takuya, Chuma Makoto, Komori Atsumasa, Kugiyama Yuki, Yasui Yutaka, Tsuchiya Kaoru, Kurosaki Masayuki, Tani Joji, Kaneko Shun, Nakagawa Mina, Asahina Yasuhiro, Maekawa Shinya, Enomoto Nobuyuki, Yamamoto Yoshiya, Baba Masaru, Yamada Ren, Sasaki Takashi, Yoda Tomoka, Yoshida Sonoe, Fu Qingjie, Yang Zijian, Maehara Osamu, Ohnishi Shunsuke, Tokuchi Yoshimasa, Kitagataya Takashi, Kawagishi Naoki, Nakai Masato, Natsuizaka Mitsuteru, Ogawa Koji, Sakamoto Naoya

Mathematical Framework to Identify Optimal Molecule Based on Virtual Ligand Strategy

基于虚拟配体策略的最优分子识别数学框架

Matsuoka, Wataru; Hirose, Ken; Yamada, Ren; Oki, Taihei; Iwata, Satoru; Maeda, Satoshi

Simplified monitoring of sofosbuvir/velpatasvir in Japanese patients with chronic hepatitis C based on a retrospective analysis of a prospective multicenter cohort

基于对前瞻性多中心队列的回顾性分析,简化日本慢性丙型肝炎患者索非布韦/维帕他韦的监测

Suda, Goki; Baba, Masaru; Yamamoto, Yoshiya; Yoshida, Sonoe; Muranaka, Tetsuhito; Meguro, Takashi; Terashita, Katsumi; Ito, Jun; Kobayashi, Tomoe; Izumi, Takaaki; Takagi, Tomofumi; Hosoda, Shunichi; Yamada, Ren; Fu, Qingjie; Yang, Zijian; Yokoyama, Daisuke; Tanaka, Takatsugu; Meno, Akimitsu; Yasuura, Naohiro; Kitagataya, Takashi; Ohara, Masatsugu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Ogawa, Koji; Sakamoto, Naoya

Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment.

基线 CXCL9 水平低可预测接受 Atezolizumab 联合 Bevacizumab 治疗的不可切除 HCC 患者的早期疾病进展

Hosoda Shunichi, Suda Goki, Sho Takuya, Ogawa Koji, Kimura Megumi, Yang Zijian, Yoshida Sonoe, Kubo Akinori, Tokuchi Yoshimasa, Kitagataya Takashi, Maehara Osamu, Ohnishi Shunsuke, Nakamura Akihisa, Yamada Ren, Ohara Masatsugu, Kawagishi Naoki, Natsuizaka Mitsuteru, Nakai Masato, Morikawa Kenichi, Furuya Ken, Baba Masaru, Yamamoto Yoshiya, Suzuki Kazuharu, Izumi Takaaki, Meguro Takashi, Terashita Katsumi, Ito Jun, Miyagishima Takuto, Sakamoto Naoya

Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150

阿特珠单抗和贝伐珠单抗治疗不符合 IMbrave150 研究入组标准的不可切除肝细胞癌患者的疗效及对肝功能储备的影响

Sho, Takuya; Suda, Goki; Yamamoto, Yoshiya; Furuya, Ken; Baba, Masaru; Ogawa, Koji; Kubo, Akinori; Tokuchi, Yoshimasa; Fu, Qingjie; Yang, Zijian; Kimura, Megumi; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Takagi, Tomofumi; Ito, Jun; Kobayashi, Tomoe; Miyagishima, Takuto; Sakamoto, Naoya

Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma.

乐伐替尼治疗期间血清生长因子的变化可预测不可切除肝细胞癌患者的进展后生存期

Yang Zijian, Suda Goki, Maehara Osamu, Ohara Masatsugu, Yoshida Sonoe, Hosoda Shunichi, Kimura Megumi, Kubo Akinori, Tokuchi Yoshimasa, Fu Qingjie, Yamada Ren, Kitagataya Takashi, Suzuki Kazuharu, Kawagishi Naoki, Nakai Masato, Sho Takuya, Natsuizaka Mitsuteru, Morikawa Kenichi, Ogawa Koji, Ohnishi Shunsuke, Sakamoto Naoya

Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication

利用丙型肝炎病毒根除后瞬时弹性成像的年龄和肝脏硬度预测肝细胞癌

Nakai, Masato; Yamamoto, Yoshiya; Baba, Masaru; Suda, Goki; Kubo, Akinori; Tokuchi, Yoshimasa; Kitagataya, Takashi; Yamada, Ren; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Sho, Takuya; Morikawa, Kenichi; Ogawa, Koji; Furuya, Ken; Sakamoto, Naoya

Case Report: Hereditary Fibrosing Poikiloderma With Tendon Contractures, Myopathy, and Pulmonary Fibrosis (POIKTMP) Presenting With Liver Cirrhosis and Steroid-Responsive Interstitial Pneumonia

病例报告:伴有肌腱挛缩、肌病和肺纤维化的遗传性纤维化性皮肤异色症(POIKTMP)合并肝硬化和激素反应性间质性肺炎

Takimoto-Sato, Michiko; Miyauchi, Toshinari; Suzuki, Masaru; Ujiie, Hideyuki; Nomura, Toshifumi; Ikari, Tomoo; Nakamura, Tomohiko; Takahashi, Kei; Matsumoto-Sasaki, Machiko; Kimura, Hirokazu; Kimura, Hiroki; Matsui, Yuichiro; Kitagataya, Takashi; Yamada, Ren; Suzuki, Kazuharu; Nakamura, Akihisa; Nakai, Masato; Sho, Takuya; Ogawa, Koji; Sakamoto, Naoya; Yamaguchi, Naoko; Otsuka, Noriyuki; Tomaru, Utano; Konno, Satoshi

Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B

替诺福韦酯富马酸酯换用替诺福韦艾拉酚胺对乙型肝炎患者血脂谱的影响

Suzuki, Kazuharu; Suda, Goki; Yamamoto, Yoshiya; Abiko, Satoshi; Kinoshita, Kenji; Miyamoto, Shuichi; Sugiura, Ryo; Kimura, Megumi; Maehara, Osamu; Yamada, Ren; Kitagataya, Takashi; Shigesawa, Taku; Ohara, Masatsugu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya